… with stage II–IIIA NSCLC, and select patients with stage IB … HRQoL scores in Chinese patients
with resected stage II–IIIA … treatments and crossover to open-label osimertinib. Finally, the …

… Baseline PRO scores reflected impaired HRQOL and functioning and considerable …
difference in time to definitive deterioration on the global health status/QOL score (0·89, 0·73–1·09). …

… of life (QOL), via patient-reported outcomes (PRO) may be helpful [6]. … that moderate or severe
patient-reported symptoms were … , and they had ≤ 1 performance status scores of Eastern …

… to assess HRQoL in cancer clinical trials, and its HCC-specific … , which are less prone to
open-label bias. Furthermore, … indicate that open-label bias did not affect these findings. Another …

… for ET and the worse body image score for the CT group would be … in the Suppression of
Ovarian Function Trial. … ] provide evidence for using BCI to select those node-positive BC …

… features, including stage II or III BC, Human Epidermal Growth … For both outcomes, we
observed slightly worse scores at year-… and 15-year survival: an overview of the randomised trials …

… primary surgery followed by systemic therapy versus primary systemic therapy without surgery
in patients with de novo stage IV BC. The present report describes QoL results of this trial. …

… results (16% PR, 53% SD, for 24 weeks). However, during the … , double-blind, placebo-controlled
multicentre phase III trial) was … An open-label, multicenter, phase III study evaluated …

… 3 CheckMate 078 trial with a 3-year minimum follow-up. … CheckMate 078 was an open-label
phase 3 study comparing … with the results from the global CheckMate 017 and 057 trials, this …

… As per the results of these studies, the planned sample size is … According to an open-label
phase 2 randomized clinical trial (… Thus, we need to investigate patient-reported outcomes (…